School of Medicine
Showing 61-80 of 91 Results
-
Philip Grant
Assistant Professor of Medicine (Infectious Diseases) at the Stanford University Medical Center
Bio My research focuses on antiretroviral therapy and complications of HIV including immune reconstitution inflammatory disease, osteoporosis, and cardiovascular disease.
-
John Graybeal
Rsch Technical Mgr 2, Med/BMIR
Current Role at Stanford John is a Technical Program Manager at Stanford University's School of Medicine. He leads the Center for Enhanced Data Annotation and Retrieval (CEDAR), and the NCBO BioPortal Repository, .
John's work encompasses whatever is needed: project management, product management, systems architecture, dev ops, and administration, to name a few fun roles. -
Harry B Greenberg
Associate Dean, Research, The Joseph D. Grant Professor in the School of Medicine and Professor of Microbiology and Immunology
Current Research and Scholarly Interests Molecular mechanisms of pathogenesis; determinants of protective immunity; host range and tissue tropism in liver and GI tract pathogenic viruses and studies of vaccines in people.
-
Peter Greenberg
Professor of Medicine (Hematology), Emeritus
Current Research and Scholarly Interests Dr Greenberg's clinical research involves design and coordination of clinical trials using experimental drugs with biologic focus for both lower and higher risk MDS patients not responding to standard therapies. These studies are particularly based on his prior laboratory investigations of gene expression and hematopoietic regulation in MDS patients. He is Coordinator of the International Working Group for Prognosis in MDS (IWG-PM) which generated the revised MDS classification system (the IPSS-R) and is now evaluating the impact of molecular mutations on this risk-based prognostic system. This project aims to use such findings to more specifically characterize and treat MDS patients. He is Chair of the NCCN Practice Guidelines Panel for MDS.
-
Jessica Grembi
Postdoctoral Research Fellow, Infectious Diseases
Bio Environmental enteric dysfunction (EED) affects 50-90% of children in low-income countries and is likely an important factor in child stunting as it impedes efficient nutrient uptake in the small intestine. EED is suspected to be the result of persistent exposure to enteric pathogens, although it has not been correlated with any specific pathogen. My research explores the interplay of gut microbiota, including enteric pathogens, and the host immune system with a focus on understanding EED so we can rationally design treatments and preventive measures.
-
Damanpreet Grewal
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Bio Being from Bay Area, I enjoy providing medical care to patients in northern California. I am excited to be part of the wonderful team of gastroenterologists at Stanford University Medical Center with its multi-disciplinary approach to caring for patients in an integrated healthcare system. I am dedicated to providing high-quality care to my patients while getting to know their personal beliefs so as to involve them in the decision-making process. Based on my education and training, I practice general gastroenterology in addition to performing endoscopies and colonoscopies.
-
Joshua Gruber
Instructor, Medicine - Oncology
Bio Dr. Joshua Gruber is an Instructor of Medicine in the division of Medical Oncology at Stanford University Medical Center. He received his Bachelors of Arts, Summa Cum Laude, in biochemistry and physics from the University of Pennsylvania in 2001. He then graduated from the Medical Scientist Training Program at the University of Pennsylvania where he performed doctoral studies in cancer biology and biochemistry. He completed internship and residency in Internal Medicine at Stanford, then was a Clinical Fellowship in Medical Oncology and also a Postdoctoral Fellow in Genetics at Stanford, working in the laboratory of Michael Snyder on integrative genomics of hereditary breast cancer. He is currently has a clinical focus on treating patients with metastatic breast cancer and triple-negative breast cancer and conducts clinical trials on novel therapeutics for these diseases. His laboratory research interests include the molecular biology of breast cancer initiation, the intersection of tumor immunology with cancer growth pathways and the development of molecular tools to interrogate neoplastic tissues.
-
Jeffrey M. Guardino
Adjunct Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Bio Dr. Guardino grew up in New York City and after completing medical school in DC at Georgetown, moved to Boston where he completed his Internal Medicine training at Harvard. He then went on to fellowship training in Cardiology while in Boston and moved to the Bay Area with his wife and family in 2000. In his spare time he enjoys hiking, skiing and reading.
